HCID 506297, compound → HCID 508023, compound
Reaction equation
[C:1]([N:9]1[CH2:14][CH2:13][N:12]([C:15](=[O:31])[C:16]([C:18]2[C:26]3[C:21](=[C:22]([C:27]([O:29]C)=[O:28])[CH:23]=[CH:24][CH:25]=3)[NH:20][CH:19]=2)=[O:17])[C@H:11]([CH3:32])[CH2:10]1)(=[O:8])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1>C([SiH](CC)CC)C.C(O)(C(F)(F)F)=O>[C:1]([N:9]1[CH2:14][CH2:13][N:12]([C:15](=[O:31])[C:16]([CH:18]2[C:26]3[C:21](=[C:22]([C:27]([OH:29])=[O:28])[CH:23]=[CH:24][CH:25]=3)[NH:20][CH2:19]2)=[O:17])[C@H:11]([CH3:32])[CH2:10]1)(=[O:8])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
1-(benzoyl)-3-(R)-methyl4-[(7-(methoxycarbonyl)indol-3-yl)-2-oxoacetyl]piperazine (50 mg) was dissolved in a solution of triethylsilane (Et3SiH, 0.5 mL) in TFA (5 mL). The reaction was stirred for 10 hours. Solvents were removed under vaccum, and the residue was purified using Shimadzu automated preparative HPLC System to give 1-benzoyl-3-(R)-methyl-4-[(7-carboxyindolin-3-yl)-2-oxoacetyl]piperazine (5.5 mg).
Workup
- customSolvents were removed under vaccum
- customthe residue was purified
Sources & evidence
- ORD record
- ord-1866c7f0c67d4116b620a74824179411
- Source dataset
- uspto-grants-2003_06
- Patent number
- US06573262B2
Reaction notes
Loading…